{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:15:51Z","timestamp":1772180151281,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2021.06.034","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:57:48Z","timestamp":1625101068000},"page":"4516-4523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0919-1240","authenticated-orcid":false,"given":"John","family":"Mwaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Cleopatra","family":"Chisenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet","family":"Ng'ombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2771-210X","authenticated-orcid":false,"given":"Elena","family":"Banda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6329-5534","authenticated-orcid":false,"given":"Chileshe","family":"Mabula-Bwalya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katayi","family":"Mwila-Kazimbaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha Makabilo","family":"Laban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1436-5911","authenticated-orcid":false,"given":"Peter","family":"Alabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6036-7320","authenticated-orcid":false,"given":"Masuzyo","family":"Chirwa-Chobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7348-2835","authenticated-orcid":false,"given":"Michelo","family":"Simuyandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita S.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2826-3887","authenticated-orcid":false,"given":"Samuel","family":"Bosomprah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5383-068X","authenticated-orcid":false,"given":"Paul","family":"Scalzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey N.","family":"Murt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malathi","family":"Ram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0151-8883","authenticated-orcid":false,"given":"Geoffrey","family":"Kwenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Sack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-9527","authenticated-orcid":false,"given":"Roma","family":"Chilengi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4006-073X","authenticated-orcid":false,"given":"Amanda K.","family":"Debes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.06.034_b0005","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1093\/infdis\/jit194","article-title":"The value of and challenges for cholera vaccines in Africa","volume":"208","author":"von Seidlein","year":"2013","journal-title":"J Infect Dis."},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.034_b0010","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS NeglTrop Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.034_b0015","first-page":"1181","article-title":"The Broad Street pump revisited: response of volunteers to ingested cholera vibrios","volume":"47","author":"Hornick","year":"1971","journal-title":"Bull N Y Acad Med."},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.034_b0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/CMR.8.1.48","article-title":"Cholera","volume":"8","author":"Kaper","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2021.06.034_b0025","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiy486","article-title":"Partners of the Global Task Force on Cholera C. Global Cholera Epidemiology: Opportunities to Reduce the Burden of Cholera by 2030","author":"Legros","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.034_b0030","unstructured":"Cholera vaccines: WHO position paper - August 2017. Wkly Epidemiol Rec. 2017;92(34):477\u201398."},{"issue":"12","key":"10.1016\/j.vaccine.2021.06.034_b0035","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"8684","key":"10.1016\/j.vaccine.2021.06.034_b0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.034_b0045","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1473-3099(18)30108-7","article-title":"Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial","volume":"18","author":"Qadri","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2021.06.034_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001867","article-title":"The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings: a modeling study","volume":"12","author":"Azman","year":"2015","journal-title":"PLoS Med."},{"issue":"46","key":"10.1016\/j.vaccine.2021.06.034_b0055","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.034_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003574","article-title":"Flexibility of oral cholera vaccine dosing-a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone","volume":"9","author":"Kanungo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2021.06.034_b0065","unstructured":"Central_Statistical_Office. Central Province, Volume 1, 2010 Census of Population and Housing Desciptive Tables. 2013."},{"issue":"46","key":"10.1016\/j.vaccine.2021.06.034_b0070","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1016\/j.vaccine.2011.08.108","article-title":"Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age","volume":"29","author":"Saha","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.034_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002828","article-title":"Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti","volume":"8","author":"Charles","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.034_b0080","article-title":"Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses","volume":"12","author":"Iyer","year":"2018","journal-title":"PLoS NeglTrop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.034_b0085","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02021-16","article-title":"Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells","volume":"7","author":"Kauffman","year":"2016","journal-title":"mBio"},{"issue":"8","key":"10.1016\/j.vaccine.2021.06.034_b0090","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1016\/S2666-5247(20)30141-5","article-title":"Vibrio cholerae O1 transmission in Bangladesh: insights from a nationally representative serosurvey","volume":"1","author":"Azman","year":"2020","journal-title":"Lancet Microbe"},{"issue":"12","key":"10.1016\/j.vaccine.2021.06.034_b0095","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.vaccine.2015.01.072","article-title":"Comparing vaccines: a systematic review of the use of the non-inferiority margin in vaccine trials","volume":"33","author":"Donken","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.034_b0100","doi-asserted-by":"crossref","first-page":"35742","DOI":"10.1038\/srep35742","article-title":"Immune responses to an oral cholera vaccine in internally displaced persons in South Sudan","volume":"6","author":"Iyer","year":"2016","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.vaccine.2021.06.034_b0105","doi-asserted-by":"crossref","first-page":"556","DOI":"10.15585\/mmwr.mm6719a5","article-title":"Cholera Epidemic - Lusaka, Zambia, October 2017-May 2018","volume":"67","author":"Sinyange","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.034_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218033","article-title":"Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India","volume":"14","author":"Raghava Mohan","year":"2019","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.034_b0115","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4269\/ajtmh.14-0683","article-title":"A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia","volume":"93","author":"Desai","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.034_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096499","article-title":"Vibriocidal antibody responses to a bivalent killed whole-cell oral cholera vaccine in a phase III trial in Kolkata, India","volume":"9","author":"Kanungo","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.034_b0125","first-page":"335","article-title":"A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate","volume":"38","author":"Mosley","year":"1968","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.034_b0130","first-page":"777","article-title":"The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients","volume":"38","author":"Mosley","year":"1968","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.034_b0135","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/infdis\/163.6.1235","article-title":"Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera","volume":"163","author":"Clemens","year":"1991","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.034_b0140","first-page":"ofz057","article-title":"Vibriocidal titer and protection from cholera in children. open forum","volume":"6","author":"Ritter","year":"2019","journal-title":"Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2021.06.034_b0145","doi-asserted-by":"crossref","first-page":"e1028","DOI":"10.1016\/S2214-109X(18)30284-5","article-title":"Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study","volume":"6","author":"Franke","year":"2018","journal-title":"Lancet Global health."},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.034_b0150","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"9479","key":"10.1016\/j.vaccine.2021.06.034_b0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.034_b0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/inthealth\/ihy085","article-title":"Herd protection of unvaccinated adults by oral cholera vaccines in rural Bangladesh","volume":"11","author":"Ali","year":"2019","journal-title":"Int Health"},{"issue":"7","key":"10.1016\/j.vaccine.2021.06.034_b0165","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.vaccine.2019.12.034","article-title":"Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine","volume":"38","author":"Chowdhury","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.034_b0170","doi-asserted-by":"crossref","first-page":"e0007057","DOI":"10.1371\/journal.pntd.0007057","article-title":"Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults","volume":"13","author":"Falkard","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.034_b0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.vaccine.2016.11.055","article-title":"Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country","volume":"35","author":"Akhtar","year":"2017","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2021.06.034_b0180","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1128\/CVI.00347-13","article-title":"Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh","volume":"20","author":"Rahman","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.06.034_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007634","article-title":"Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh","volume":"13","author":"Akter","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.034_b0190","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.vaccine.2012.11.012","article-title":"Immune responses and protection in children in developing countries induced by oral vaccines","volume":"31","author":"Qadri","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.034_b0195","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1473-3099(18)30662-5","article-title":"Enhancing immune responses to oral vaccines: still an enigma","volume":"19","author":"Sack","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:58:09Z","timestamp":1759402689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21007702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":39,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0264410X21007702"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}